Arcturus Therapeutics Holdings, Inc. (ARCT)
6.505
+0.08
(+1.17%)
USD |
NASDAQ |
Dec 24, 12:59
Arcturus Therapeutics Holdings SG&A Expense (TTM): 44.43M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 33.07M |
| Perspective Therapeutics, Inc. | 31.53M |
| Novavax, Inc. | 201.70M |
| Sangamo Therapeutics, Inc. | 36.99M |
| Myomo, Inc. | 32.71M |